医学
鼻咽癌
内科学
肿瘤科
化疗
阶段(地层学)
放化疗
放射治疗
生物
古生物学
作者
Qiao He,Yecai Huang,Gang Wan,Mei Feng,Huamin Zeng,Mengru Liu,Huaichao Luo,Yuanyuan Yang,Xiaoyu Song,Li Zhang,Jinyi Lang
标识
DOI:10.2217/bmm-2018-0401
摘要
Aim: To evaluate the prognostic value of pretreatment prognostic nutritional index (PNI) in nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy. Materials & methods: We conducted a retrospective study on prognostic value of PNI in NPC patients. A new prognostic marker was explored based on risk stratification with PNI and age. Results: PNI and age were two independent prognostic factors for overall survival (OS) and progression free survival besides node stage and clinical stage. Low prognostic nutritional index and high age (LPNI–HAge) was identified as an independent prognostic factor for both OS (p < 0.001) and progression free survival (p = 0.008), which has a better predict value than sole PNI or age. Conclusion: The novel prognosis index LPNI-HAge provides prognostication of OS and progression free survival for NPC patients treated with neoadjuvant chemotherapy plus concurrent chemoradiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI